+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hematology Diagnostics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2018-2026

  • ID: 4852004
  • Report
  • May 2018
  • Region: Global
  • 228 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Global Hematology Diagnostics Market - Overview

Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets. The analysis for hematologic disorders is related to disease monitoring, prognosis, diagnosis, and screening. Rise in prevalence of blood disorders, technological advancements and introduction of new technically advanced fully automated hematology analyzers, significant demand for laboratory automation, and increase in consolidation among market players and diagnostic laboratories are key factors that are expected to drive the global hematology diagnostics market during the forecast period.

The hematology diagnostics market has been segmented based on product type, end-user, and geography. Based on product type, the hematology diagnostics market has been classified into hematology instruments and hematology consumables. In terms of end-user, the market has been segregated into diagnostic laboratories, hospitals & clinics, academic institutes, and others. Based on geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the hematology diagnostics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product, application and geography for the period 2017 to 2026, considering the macro and micro environmental factors. The revenue generated from each product and application was calculated by considering the hematology diagnostics market product sales.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that influence the hematology diagnostics market in the current and future scenario. The report also provides the Porter’s five forces analysis, the acquisitions timeline of the hematology diagnostics market companies, SWOT analysis of the market, key vendor and distributor analysis, and comparative analysis of the hematology diagnostics market.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the hematology diagnostics market.

The report also profiles the major players operating in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the hematology diagnostics market report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthineers, HORIBA, Ltd., HemoCue AB, and Danaher (Beckman Coulter, Inc.).

The hematology diagnostics market has been segmented as follows:

  • Hematology Diagnostics Market, by Product Type
    • Hematology Instruments
      • Hematology Analyzers
        • Fully-automated Hematology Analyzers
        • Semi-automated Hematology Analyzers
      • Flow Cytometers
      • Others
    • Hematology Consumables
      • Reagents
      • Stains
      • Controls & Calibrators
      • Others
  • Hematology Diagnostics Market, by End-user
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Academic Institutes
    • Others
  • Hematology Diagnostics Market Revenue, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K
      • Germany
      • Spain
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of MEA
Note: Product cover images may vary from those shown
2 of 2
Section 01 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 02 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 03 Executive Summary
3.1 Global Hematology Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2026
3.2 Global Hematology Diagnostics Market Snapshot, 2017
3.3 Global Hematology Diagnostics Market: Opportunity Map

Section 04 Market Overview
4.1 Overview
4.2 Global Hematology Diagnostics Market Size (US$ Mn) Forecast, 2016-2026
4.3 Global Hematology Diagnostics Market Outlook
4.4 Global Hematology Diagnostics Market: Porter’s Five Forces Analysis
4.5 Hematology Analyzers Installed Base
4.6 Key Success factor for Top 3 Players
4.7 Technological Advancements
4.8 Disease Prevalence & Incidence Rate Globally with Key Countries

Section 05 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends

Section 06 Hematology Diagnostics Market Analysis, by Product Type
6.1 Introduction
6.2 Global Hematology Diagnostics Market Value Share Analysis, by Product Type
6.3 Hematology Diagnostics Market Analysis, by Product Type
6.3.1 Hematology Instruments
6.3.1.1 Hematology Analyzers
6.3.1.1.1 Fully-automated Hematology Analyzers
6.3.1.1.2 Semi-automated Hematology Analyzers
6.3.1.2 Flow Cytometers
6.3.1.3 Others
6.3.2 Hematology Consumables
6.3.2.1 Reagents
6.3.2.2 Stains
6.3.2.3 Controls & Calibrators
6.3.2.4 Others
6.4 Hematology Diagnostics Market Attractiveness Analysis, by Product Type
6.5 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Analyzers
6.6 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables

Section 07 Hematology Diagnostics Market Analysis, by End-user
7.1 Introduction
7.2 Global Hematology Diagnostics Market Value Share Analysis, by End-user
7.3 Hematology Diagnostics Market Analysis, by End-user
7.3.1 Diagnostic Laboratories
7.3.2 Hospitals & Clinics
7.3.3 Academic Institutes
7.3.4 Others
7.4 Hematology Diagnostics Market Attractiveness Analysis, by End-user

Section 08 Hematology Diagnostics Market Analysis, by Region
8.1 Global Hematology Diagnostics Market Snapshot, by Country
8.2 Global Hematology Diagnostics Market Value Share Analysis, by Region
8.3 Hematology Diagnostics Market Forecast, by Region
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 Hematology Diagnostics Market Attractiveness Analysis, by Region
8.5 Hematology Diagnostics Market: Regional Trends

Section 09 North America Hematology Diagnostics Market Analysis
9.1 Key Findings
9.2 North America Hematology Diagnostics Market Overview
9.3 North America Market Value Share Analysis, by Product Type
9.4 North America Market Forecast, by Product Type
9.4.1 Hematology Instruments
9.4.2 Hematology Consumables
9.5 North America Market Value Share Analysis, by Hematology Instruments
9.6 North America Market Forecast, by Hematology Instruments
9.6.1 Hematology Analyzers
9.6.2 Flow Cytometers
9.6.3 Others
9.7 North America Market Value Share Analysis, by Hematology Consumables
9.8 North America Market Forecast, by Hematology Consumables
9.8.1 Reagents
9.8.2 Stains
9.8.3 Controls & Calibrators
9.8.4 Others
9.9 North America Market Value Share Analysis, by End-user
9.10 North America Market Forecast, by End-user
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals & Clinics
9.10.3 Academic Institutes
9.10.4 Others
9.11 Market Analysis, by Country
9.12 Market Value Share Analysis, by Country
9.13 Market Size (US$ Mn) Forecast, by Country, 2018-2026
9.13.1 U.S.
9.13.2 Canada
9.14 Market Attractiveness Analysis
9.14.1 by Product Type
9.14.2 by Hematology Instruments
9.14.3 by Hematology Consumables
9.14.4 by End-user
9.14.5 by Country

Section 10 Europe Hematology Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe Hematology Diagnostics Market Overview
10.3 Europe Market Value Share Analysis, by Product Type
10.4 Europe Market Forecast, by Product Type
10.4.1 Hematology Instruments
10.4.2 Hematology Consumables
10.5 Europe Market Value Share Analysis, by Hematology Instruments
10.6 Europe Market Forecast, by Hematology Instruments
10.6.1 Hematology Analyzers
10.6.2 Flow Cytometers
10.6.3 Others
10.7 Europe Market Value Share Analysis, by Hematology Consumables
10.8 Europe Market Forecast, by Hematology Consumables
10.8.1 Reagents
10.8.2 Stains
10.8.3 Controls & Calibrators
10.8.4 Others
10.9 Europe Market Value Share Analysis, by End-user
10.10 Europe Market Forecast, by End-user
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals & Clinics
10.10.3 Academic Institutes
10.10.4 Others
10.11 Market Analysis, by Country
10.12 Market Value Share Analysis, by Country
10.13 Market Size (US$ Mn) Forecast, by Country, 2018-2026
10.13.1 Germany
10.13.2 France
10.13.3 U.K.
10.13.4 Italy
10.13.5 Spain
10.13.6 Rest of Europe
10.14 Market Attractiveness Analysis
10.14.1 by Product Type
10.14.2 by Hematology Instruments
10.14.3 by Hematology Consumables
10.14.4 by End-user
10.14.5 by Country

Section 11 Asia Pacific Hematology Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Hematology Diagnostics Market Overview
11.3 Asia Pacific Market Value Share Analysis, by Product Type
11.4 Asia Pacific Market Forecast, by Product Type
11.4.1 Hematology Instruments
11.4.2 Hematology Consumables
11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments
11.6 Asia Pacific Market Forecast, by Hematology Instruments
11.6.1 Hematology Analyzers
11.6.2 Flow Cytometers
11.6.3 Others
11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables
11.8 Asia Pacific Market Forecast, by Hematology Consumables
11.8.1 Reagents
11.8.2 Stains
11.8.3 Controls & Calibrators
11.8.4 Others
11.9 Asia Pacific Market Value Share Analysis, by End-user
11.10 Asia Pacific Market Forecast, by End-user
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals & Clinics
11.10.3 Academic Institutes
11.10.4 Others
11.11 Market Analysis, by Country
11.12 Market Value Share Analysis, by Country
11.13 Market Size (US$ Mn) Forecast, by Country, 2018-2026
11.13.1 China
11.13.2 Japan
11.13.3 India
11.13.4 Australia & New Zealand
11.13.5 Rest of Asia Pacific
11.14 Market Attractiveness Analysis
11.14.1 by Product Type
11.14.2 by Hematology Instruments
11.14.3 by Hematology Consumables
11.14.4 by End-user
11.14.5 by Country

Section 12 Latin America Hematology Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America Hematology Diagnostics Market Overview
12.3 Latin America Market Value Share Analysis, by Product Type
12.4 Latin America Market Forecast, by Product Type
12.4.1 Hematology Instruments
12.4.2 Hematology Consumables
12.5 Latin America Market Value Share Analysis, by Hematology Instruments
12.6 Latin America Market Forecast, by Hematology Instruments
12.6.1 Hematology Analyzers
12.6.2 Flow Cytometers
12.6.3 Others
12.7 Latin America Market Value Share Analysis, by Hematology Consumables
12.8 Latin America Market Forecast, by Hematology Consumables
12.8.1 Reagents
12.8.2 Stains
12.8.3 Controls & Calibrators
12.8.4 Others
12.9 Latin America Market Value Share Analysis, by End-user
12.10 Latin America Market Forecast, by End-user
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals & Clinics
12.10.3 Academic Institutes
12.10.4 Others
12.11 Market Analysis, by Country
12.12 Market Value Share Analysis, by Country
12.13 Market Size (US$ Mn) Forecast, by Country, 2018-2026
12.13.1 Brazil
12.13.2 Mexico
12.13.3 Rest of Latin America
12.14 Market Attractiveness Analysis
12.14.1 by Product Type
12.14.2 by Hematology Instruments
12.14.3 by Hematology Consumables
12.14.4 by End-user
12.14.5 by Country

Section 13 Middle East & Africa Hematology Diagnostics Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Hematology Diagnostics Market Overview
13.3 Middle East & Africa Market Value Share Analysis, by Product Type
13.4 Middle East & Africa Market Forecast, by Product Type
13.4.1 Hematology Instruments
13.4.2 Hematology Consumables
13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments
13.6 Middle East & Africa Market Forecast, by Hematology Instruments
13.6.1 Hematology Analyzers
13.6.2 Flow Cytometers
13.6.3 Others
13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables
13.8 Middle East & Africa Market Forecast, by Hematology Consumables
13.8.1 Reagents
13.8.2 Stains
13.8.3 Controls & Calibrators
13.8.4 Others
13.9 Middle East & Africa Market Value Share Analysis, by End-user
13.10 Middle East & Africa Market Forecast, by End-user
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals & Clinics
13.10.3 Academic Institutes
13.10.4 Others
13.11 Market Analysis, by Country
13.12 Market Value Share Analysis, by Country
13.13 Market Size (US$ Mn) Forecast, by Country, 2018-2026
13.13.1 GCC Countries
13.13.2 South Africa
13.13.3 Rest of Middle East & Africa
13.14 Market Attractiveness Analysis
13.14.1 By Product Type
13.14.2 by Hematology Instruments
13.14.3 by Hematology Consumables
13.14.4 by End-user
13.14.5 by Country

Section 14 Competition Landscape
14.1 Competition Matrix
14.2 Hematology Diagnostics Market Share Analysis, by Company (2017)
14.3 Company Profiles
14.3.1 Abbott Laboratories
14.3.1.1 Company Description
14.3.1.2 Financial Overview
14.3.1.3 Strategy & Recent Developments
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories, Inc.
14.3.2.1 Company Description
14.3.2.2 Financial Overview
14.3.2.3 Strategy & Recent Developments
14.3.2.4 SWOT Analysis
14.3.3 Sysmex Corporation
14.3.3.1 Company Description
14.3.3.2 Financial Overview
14.3.3.3 Strategy & Recent Developments
14.3.3.4 SWOT Analysis
14.3.4 Mindray Medical International Limited
14.3.4.1 Company Description
14.3.4.2 Financial Overview
14.3.4.3 Strategy & Recent Developments
14.3.4.4 SWOT Analysis
14.3.5 Siemens Healthineers
14.3.5.1 Company Description
14.3.5.2 Financial Overview
14.3.5.3 Strategy & Recent Developments
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd.
14.3.6.1 Company Description
14.3.6.2 Financial Overview
14.3.6.3 Strategy & Recent Developments
14.3.6.4 SWOT Analysis
14.3.7 HORIBA, Ltd.
14.3.7.1 Company Description
14.3.7.2 Financial Overview
14.3.7.3 Strategy & Recent Developments
14.3.7.4 SWOT Analysis
14.3.8 HemoCue AB
14.3.8.1 Company Description
14.3.8.2 Financial Overview
14.3.8.3 Strategy & Recent Developments
14.3.8.4 SWOT Analysis
14.3.9 Danaher (Beckman Coulter, Inc.)
14.3.9.1 Company Description
14.3.9.2 Financial Overview
14.3.9.3 Strategy & Recent Developments
14.3.9.4 SWOT Analysis
Note: Product cover images may vary from those shown
Adroll
adroll